-
Angiotensin II: Vascular Research Workflows
2026-09-12
Build reproducible hypertension, vascular remodeling, and aneurysm experiments with a defined Angiotensin II peptide workflow. This guide connects practical dosing and handling decisions with orthogonal signaling assays, while clearly separating established cardiovascular applications from kidney-fibrosis mechanisms that remain hypothesis-generating.
-
SIRT1, Mitochondrial Biogenesis, and Prion Toxicity
2026-09-12
A 2024 study identifies SIRT1-dependent PGC-1α–TFAM signaling as a mechanistic link between mitochondrial biogenesis and neuronal injury caused by the prion peptide PrP106–126 in N2a cells. The findings position Resveratrol as a pharmacological probe for this pathway while highlighting the need to distinguish SIRT1-mediated mitochondrial rescue from broader antioxidant or anti-apoptotic effects.
-
Angiotensin II: From Vascular Signals to AAA Insight
2026-09-11
A translational framework for using Angiotensin II to connect GPCR signaling, oxidative stress, vascular remodeling, and abdominal aortic aneurysm models—while interpreting environmental exposure findings with appropriate mechanistic and experimental limits.
-
Tofacitinib Workflow for RA Macrophage Assays
2026-09-11
Build reproducible RA macrophage experiments around Tofacitinib, from DMSO stock preparation and GM-CSF challenge design to STAT5, cytokine, and mitochondrial readouts. The workflow distinguishes pathway inhibition from metabolic rescue and translates recent mechanistic findings into practical controls, dose ranges, and troubleshooting decisions.
-
Rucaparib Workflows for DNA Repair Research
2026-09-10
Rucaparib (AG-014699) provides a practical PARP1 inhibition tool for testing DNA damage persistence, radiation response, and repair-deficient cancer phenotypes. This workflow connects prostate cancer radiosensitization with emerging SmD2–BRCA1/FANC splicing biology in hepatocellular carcinoma.
-
Defined Culture for Human Intestinal Organoids
2026-09-10
Meghan M. Capeling’s dissertation presents a defined, modular culture strategy for human intestinal organoids, including non-adhesive alginate hydrogels and methods for separating epithelial and mesenchymal compartments. The work provides a practical framework for improving experimental control, reproducibility, and physiological interpretation in studies of human intestinal development.
-
SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis
2026-09-09
The reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced chronic kidney disease, linking its inhibition with reduced renal fibrosis, epithelial–mesenchymal transition, and inflammation. By evaluating AZ505 and LLY-507 in experimental kidney injury and tubular epithelial-cell models, the work supports SMYD2–Smad3/STAT3 signaling as a mechanistic framework for renal fibrosis research.
-
Tomivosertib: MNK1 Inhibitor Workflow Guide
2026-09-09
Tomivosertib is a selective MNK1/2 inhibitor for connecting eIF4E phosphorylation with tumor growth, angiogenesis, neuronal activity, and metabolic regulation. This practical guide translates its mechanism into cell-based, combination-treatment, endothelial, and exploratory in vivo workflows, with troubleshooting points for reproducible results.
-
Cepharanthine: An Evidence-Weighted Assay Framework
2026-09-08
Cepharanthine is a biscoclaurine alkaloid with evidence spanning DNA damage, cell-cycle arrest, apoptosis, organoid biology, and tumor research. This article presents an evidence-weighted strategy for selecting assays, interpreting cross-model results, and avoiding overstatement in translational studies.
-
Phytol and Assay Design: Lessons from Soft Matter
2026-09-08
Phytol is more than an RXR ligand: its isomeric composition, solvent behavior, metabolism, and GABAergic actions can shape assay interpretation. This article develops a matrix-aware experimental framework inspired by recent polymer self-assembly research.
-
Nile Red for Laryngeal Cancer Lipid Imaging
2026-09-07
Use Nile Red as a dual-channel fluorescent lipid probe to connect intracellular lipid-droplet phenotypes with THBS1-associated laryngeal cancer research. This workflow distinguishes lipid-droplet signal from membrane-associated fluorescence and adds quantitative lipid imaging to genomic, proliferation, and migration assays.
-
Resazurin Cell Viability Assay for Apoptosis Studies
2026-09-05
Build a sensitive, non-toxic cell viability assay around resazurin reduction, then connect metabolic changes to apoptosis with orthogonal validation. This workflow is especially useful for dose–response screening, lymphoid malignancy research, and high-throughput cell proliferation assay development.
-
Y-27632 Workflows for iPSC Airway Assays
2026-09-05
Y-27632 helps researchers separate ROCK-dependent morphology and recovery effects from genotype-specific epithelial function in iPSC-derived airway models. This practical guide connects transient ROCK inhibition with 3D swelling, planar mucociliary cultures, cytoskeletal imaging, and troubleshooting for CFTR-focused experiments.
-
Vidarabine Monohydrate in Antiviral Workflows
2026-09-04
Vidarabine monohydrate is a DMSO-compatible antiviral research compound for probing viral DNA synthesis, replication timing, and nucleoside analog responses. This workflow-focused guide covers stock preparation, infection assays, orthogonal readouts, controls, and troubleshooting for more reproducible virology experiments.
-
DiscoveryProbe Bioactive Compound Library Plus Guide
2026-09-04
The DiscoveryProbe Bioactive Compound Library Plus is a 5,072-compound research collection for pathway-focused screening and assay development. Its pre-dissolved 10 mM DMSO format supports practical high-throughput workflows, while thermal-shift assay literature provides a framework for ligand-screening controls and orthogonal validation.